2014
DOI: 10.1007/s00256-014-1881-y
|View full text |Cite
|
Sign up to set email alerts
|

The development and implementation of an outcomes database for imaging-guided therapeutic musculoskeletal injections

Abstract: Setting up an outcomes database is straightforward and productive. The NRS and PGIC were considered the most useful outcome measures. This database facilitated critical reflection on current practice and provides the foundation for several research studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…25 However, when comparing the results of the entire CNRI cohort of 52 patients in this study where 49% were "improved" at 3 months with the shorter-term 1-month outcomes of all CNRI patients (n = 195) currently listed in the radiology database, there is surprisingly little difference, as only 43% of patients reported clinically relevant improvement even at the 1-month data collection time point. 26 Therefore, the longer data collection time point of 3 months does not appear to have been a negative factor in the proportion of clinically improved CNRI patients. Comparing the treatment costs between the SMT and CNRI patients shows a minimal difference of only CHF 42.47 even though the SMT patients were treated multiple times.…”
Section: Discussionmentioning
confidence: 98%
“…25 However, when comparing the results of the entire CNRI cohort of 52 patients in this study where 49% were "improved" at 3 months with the shorter-term 1-month outcomes of all CNRI patients (n = 195) currently listed in the radiology database, there is surprisingly little difference, as only 43% of patients reported clinically relevant improvement even at the 1-month data collection time point. 26 Therefore, the longer data collection time point of 3 months does not appear to have been a negative factor in the proportion of clinically improved CNRI patients. Comparing the treatment costs between the SMT and CNRI patients shows a minimal difference of only CHF 42.47 even though the SMT patients were treated multiple times.…”
Section: Discussionmentioning
confidence: 98%
“…Reasons for this gender discrepancy One strength of this study is that it is a prospective outcome study, using two simple and validated outcome measures. 14,15 Secondly, this study examines three well-defined categories of intra-articular hip pathologies in patients over age 40. This results in a homogeneous middle age and older patient group with degenerative pathologies, excluding growing disorders or conditions manifest in younger populations.…”
Section: Discussionmentioning
confidence: 99%
“…Pochon et al therapeutic injections and were described in previous studies as "the most valid, reliable, and time-effective outcome measures. " 14,15 The PGIC is a 7-point scale including the responses "much better," "better," "slightly better," "unchanged," "slightly worse," "worse" and "much worse." This scale includes the subjective improvement in terms of activity limitations, symptoms, emotions and overall quality of life.…”
Section: Bjrmentioning
confidence: 99%
See 2 more Smart Citations